BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 38501059)

  • 1. Investigating the potential neuroprotective benefits of taurine and Dihydrotestosterone and Hydroxyprogesterone levels in SH-SY5Y cells.
    Almohaimeed HM; Almars AI; Alsulaimani F; Basri AM; Althobaiti NA; Albalaw AE; Alsharif I; Al Abdulmonem W; Hershan AA; Soliman MH
    Front Aging Neurosci; 2024; 16():1379431. PubMed ID: 38867846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-3940-5p reduces amyloid β production via selectively targeting
    Qi Y; Wang X; Guo X
    Front Aging Neurosci; 2024; 16():1346978. PubMed ID: 38501059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of miR-96-5p May Reduce Aβ42/Aβ40 Ratio via Regulating ATP-binding cassette transporter A1.
    Zhu M; Jia L; Jia J
    J Alzheimers Dis; 2021; 83(1):367-377. PubMed ID: 34334400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
    Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
    Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1.
    Li J; Wang H
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Small Extracellular Vesicle-Derived miR-342-5p Ameliorates Beta-Amyloid Formation via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer's Disease.
    Dong Z; Gu H; Guo Q; Liu X; Li F; Liu H; Sun L; Ma H; Zhao K
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presenilin-1, mutated in familial Alzheimer's disease, maintains genome stability via a γ-secretase dependent way.
    Guo X; Jiang M; Dai X; Shen J; Wang X
    DNA Repair (Amst); 2023 Nov; 131():103580. PubMed ID: 37804602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of circ_0004381 improves cognitive function via miR-647/PSEN1 axis in an Alzheimer disease mouse model.
    Li N; Zhang D; Guo H; Yang Q; Li P; He Y
    J Neuropathol Exp Neurol; 2022 Dec; 82(1):84-92. PubMed ID: 36409993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting
    Wuli W; Lin SZ; Chen SP; Tannous BA; Huang WS; Woon PY; Wu YC; Yang HH; Chen YC; Fleming RL; Rogers JT; Cahill CM; Ho TJ; Chiou TW; Harn HJ
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142465
    [No Abstract]   [Full Text] [Related]  

  • 11. MiR-29c-3p May Promote the Progression of Alzheimer's Disease through BACE1.
    Cao Y; Tan X; Lu Q; Huang K; Tang X; He Z
    J Healthc Eng; 2021; 2021():2031407. PubMed ID: 34956559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm.
    Grabowska-Pyrzewicz W; Want A; Leszek J; Wojda U
    EBioMedicine; 2021 Dec; 74():103691. PubMed ID: 34773891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different miRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative Diseases.
    Sproviero D; Gagliardi S; Zucca S; Arigoni M; Giannini M; Garofalo M; Olivero M; Dell'Orco M; Pansarasa O; Bernuzzi S; Avenali M; Cotta Ramusino M; Diamanti L; Minafra B; Perini G; Zangaglia R; Costa A; Ceroni M; Perrone-Bizzozero NI; Calogero RA; Cereda C
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800495
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.